BK2246 Healthcare Plans
- 1677.943
- +4.187+0.25%
Centene Is Maintained at Overweight by Barclays
Centene Is Maintained at Overweight by Barclays
Centene Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/02/2024 42.7% Barclays $101 → $104 Maintains Overweight 04/30/2024 12.51% Deutsche Bank $81 → $82 Maint
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $16,000 Today
Cigna Group (NYSE:CI) has outperformed the market over the past 15 years by 7.82% on an annualized basis producing an average annual return of 19.7%. Currently, Cigna Group has a market capitalization
Express News | CVS Health Corp : UBS Cuts to Neutral From Buy
Express News | CVS Health Shares Are Trading Lower After UBS Downgraded the Stock From Buy to Neutral and Lowered Its Price Target From $85 to $60
Express News | Cigna Exec Says Booked About $650 Mln in Incremental Reserves in Cigna Healthcare Relating to Change Healthcare Disruption
CVS Health Price Target Cut to $60.00/Share From $85.00 by UBS
CVS Health Price Target Cut to $60.00/Share From $85.00 by UBS
Express News | Cigna Exec Says Co Saw "Some Disruption to Claim Submissions and Payments" in Q1 Due to Change Healthcare Cyber Attack
Sector Update: Health Care Stocks Mixed Premarket Thursday
Health care stocks were mixed premarket Thursday as the iShares Biotechnology ETF (IBB) was inactive and the Health Care Select Sector SPDR Fund (XLV) was up 0.4% recently. Becton, Dickinson (BDX) adv
Express News | Wellcare and Wellvana Announce Partnership to Expand Patient-Centered Primary Care for Benefit of Medicare Advantage Members in Georgia, Tennessee and Texas
CVS Health Cut to Neutral at UBS on Q1 Miss
Expert Outlook: CVS Health Through The Eyes Of 11 Analysts
Analysts' ratings for CVS Health (NYSE:CVS) over the last quarter vary from bullish to bearish, as provided by 11 analysts.The table below provides a snapshot of their recent ratings, showcasing how s
Express News | Cigna Exec Says Regulatory Review by the US DOJ of Co's Deal to Sell Medicare Business to Health Care Service Corp Is Complete - Conf Call
CVS Health (CVS) Receives a Rating Update From a Top Analyst
Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT), Cross Country Healthcare (CCRN) and CVS Health (CVS)
CVS Health Is Maintained at Buy by Mizuho
CVS Health Is Maintained at Buy by Mizuho
Express News | Mizuho Maintains Buy on CVS Health, Lowers Price Target to $72
Returns At Centene (NYSE:CNC) Appear To Be Weighed Down
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for? In a perfect world, we'd like to see a company investing more capital into its bu
CVS Health First Quarter 2024 Earnings: EPS Misses Expectations
Fed, Earnings Outlooks Lift Wall Street Pre-Bell; Asia Mixed, Europe Off
Wall Street futures pointed moderately higher pre-bell Thursday after Federal Reserve Chair Jerome Powell on Wednesday appeared to rule out rate hikes for 2024, and following disclosures that the cent